Abstract
Fungi are pathogens that commonly infect immunocompromised patients and can affect any organs of the body, including the colon. However, the literature provides limited details on colonic infections caused by fungi. This article is an intensive review of information available on the fungi that can cause colon infections. It uses a comparative style so that its conclusions may be accessible for clinical application.
Keywords: fungus, colitis, large bowel, large intestine
Introduction
Fungi are pathogens that commonly infect immunocompromised patients. At present, the incidence of these pathogens in disease causation is gradually increasing as a result of increased use of immunosuppressive drugs, chemotherapy, and transplantation as well as infections with the human immunodeficiency virus. Fungal infections can affect any organ, including the colon.1–3 Nevertheless, only limited details of colonic infection caused by fungi are available in the literature.4,5 This article aims to provide an intensive review of research on fungal infection of the colon in a concise, comparative style for easy clinical application.
Methods
The author initiated the review by researching fungi that can cause colonic infection on MEDLINE, in major textbooks, and existing research literature that review fungal infections of the colon.4–7 In MEDLINE, the author used keywords from two groups. The first group consisted of names of the fungi or infections related to the fungi, including “aspergillosis”, “Aspergillus”, “Blastomyces”, “blastomycosis”, “Candida”, “candidiasis”, “chromoblastomycosis”, “Cladophialophora”, “Coccidioides”, “ coccidioidomycosis”, “cryptococcosis”, “Cryptococcus”, “dermatophyte”, “dermatophytosis”, “Epidermophyton”, “eumycetoma”, “Fonsecaea”, “fusariosis”, “Fusarium”, “Histoplasma”, “histoplasmosis”, “Madurella”, “Microsporum”, “mucormycosis”, “Paracoccidioides”, “paracoccidioidomycosis”, “penicilliosis”, “Penicillium”, “phaeohyphomycosis”, “ Pneumocystis”, “pneumocystosis”, “scedosporiosis”, “Scedosporium”, “Sporothrix”, “sporotrichosis”, “Trichophyton”, “Trichosporon”, “trichosporonosis”, “Zygomycetes”, and “zygomycosis”. The second group of keywords consisted of words related to locations of the disease under our focus, including “colitis”, “colon”, “colonic”, “ enterocolitis”, “large bowel”, “large intestinal”, and “large intestine”. Finally, it was determined that infections of the colon that have been reported to be caused by fungi were aspergillosis, candidiasis, cryptococcosis, histoplasmosis, paracoccidioidomycosis, penicilliosis, pneumocystosis, scedosporiosis, and zygomycosis. Details of each fungus were further reviewed from articles retrieved on MEDLINE using the keywords as described above, citations to these articles, and references in major textbooks. In MEDLINE, all types of articles, including reviews, case series, case reports, editorials, and letters, up to June 30, 2014 were included. Initially, 124 articles were found. Only articles which were in English or had an English-language abstract with complete necessary detail that had a definite diagnosis of fungal infection of the colon, including direct visualization of typical fungus or positive fungal culture in colonic specimens, were selected. Cases of candidiasis, which is considered a normal commensal of the human gastrointestinal tract, also needed to have one of the following criteria as per the accepted case reports and revised European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria: deep tissue invasion in the colon, or positive Candida spp. in superficial mucosa with positive blood culture, or positive Candida spp. in superficial mucosa with evidence in response to treatment.8–14 Candida spp. in only superficial mucosa without positive blood culture or evidence in response to treatment were excluded. Dissemination was defined as involvement of two or more noncontiguous organs.15–19
At present, histoplasmosis,20,21 candidiasis,13 and zygomycosis22–25 have already been reviewed. In cases of other fungal infections, including cryptococcosis,26–35 penicilliosis,36–38 aspergillosis,9,39–44 and paracoccidioidomycosis,45–50 the author summarized case reports, as shown in Tables 1–4. Only one case report was published for each of pneumocystosis51 and scedosporiosis.52
Table 1.
Source, year | Age (years)/sex | Origin of report | Underlying disease/medication | Clinical presentations | Duration of onset | Dissemination | Colonic distribution | Endoscopic finding | Treatment and outcome |
---|---|---|---|---|---|---|---|---|---|
Zelman et al,26 1951 | 25/male | USA | CML, chemotherapy | Not mentioned | Not mentioned | Yes | Not mentioned | Ulcer | None → died |
Unat et al,27 1960 | 16/male | Turkey | None | Diarrhea, abdominal pain, LGIB | 8 years | No | Descending colon | Mass | Surgery and amphotericin B → improved |
Hutto et al,28 1988 | 29/female | USA | Job’s syndrome | Rectal abscess | 1 year | No | Perirectum, ascending colon | Stricture at ascending colon and perirectal abscess | Surgery and amphotericin B → improved |
Van Calck et al,29 1988 | 47/male | Belgium | AIDS | Hematochezia, fever | Not mentioned | Yes | Perirectum | Perirectal abscess | Surgery, amphotericin B and flucytosine → improved |
Daly et al,30 1990 | 63/male | USA | Cirrhosis, splenectomy, corticosteroids | Fever, chills, malaise | 7 days | Yes | Transverse colon | Mass | Amphotericin B and flucytosine → died |
Bonacini et al,31 1990 | 31/male | USA | AIDS | Hemiplegia, seizure | Not mentioned | Yes | Not mentioned | Not mentioned | Amphotericin B and flucytosine → died |
Washington et al,32 1991 | 38/male | USA | AIDS | Epigastric pain, odynophagia | 3 months | Yes | Cecum | Not mentioned | Antifungal therapy → died |
Washington et al,32 1991 | 24/male | USA | Hodgkin’s disease | Not mentioned | Not mentioned | Yes | Not mentioned | Not mentioned | None → died |
Washington et al,32 1991 | 31/female | USA | AIDS | Not mentioned | Not mentioned | Yes | Not mentioned | Not mentioned | None → died |
Washington et al,32 1991 | 51/male | USA | Corticosteroids | Not mentioned | Not mentioned | Yes | Not mentioned | Not mentioned | None → died |
Melato and Gorji,33 1998 | 84/female | Italy | None | Rectal bleeding | Acute | No | Sigmoid colon | Polyp | Polypectomy → improved |
Law et al,34 2007 | 40/male | Canada | AIDS | Abdominal pain, diarrhea, dysphagia, fever | 6 weeks | Yes | Left colon | Multiple erythematous, raised, patchy lesions | Amphotericin B and flucytosine → improved |
Song et al,35 2008 | 27/female | Korea | None | Melena | Not mentioned | No | Proximal ascending colon | Mass | Amphotericin B and fluconazole → improved |
Abbreviations: AIDS, acquired immunodeficiency syndrome; CML, chronic myeloid leukemia; LGIB, lower gastrointestinal bleeding.
Table 4.
Source, year | Age(years)/sex | Origin of report | Underlying disease/medication | Clinical presentations | Duration of onset | Dissemination | Colonic distribution | Endoscopic finding | Treatment and outcome |
---|---|---|---|---|---|---|---|---|---|
Penna,45 1979 | 8/female | Brazil | None | Diarrhea, abdominal pain, abdominal distension, fever, failure to thrive | 4 years | No | Whole colon | Stricture, ulcer | Co-trimoxazole → improved |
Chojniak et al,46 2000 | 57/not mentioned | Brazil | None | Abdominal pain, diarrhea, weight loss | 2 years | No | Cecum | Mass | Ketoconazole → not mentioned |
Costa Vieira et al,47 2001 | 60/male | Brazil | None | Fever, perianal nodule, dysphonia, cough, dyspnea weight loss | 2 years | Yes | Transverse and Descending colons | Ulcer | Sulfadiazine → improved |
Bravo et al,48 2010 | 39/female | Peru | None | Diarrhea, abdominal pain, fever, weight loss | 2 months | Yes | Whole colon | Ulcer | Amphotericin B → died |
Leon et al,49 2010 | 34/male | Peru | None | Diarrhea, oral ucers, odynophagia, weight loss, cough | 18 months | Yes | Whole colon | Ulcer | Amphtotericin B and itraconazole → improved |
Leon et al,49 2010 | 40/female | Peru | None | Diarrhea, weight loss, hepatomegaly | 1 year | Yes | Not mentioned | Not mentioned | Amphotericin B → died |
Benard et al,50 2013 | 56/female | Brazil | None | None (colonoscopy for check up) | Unknown | No | Transverse colon | Polyp | Itraconazole → improved |
Benard et al,50 2013 | 58/female | Brazil | None | Diarrhea, weight loss, fever | 6 months | No | Whole colon | Ulcer | Itraconazole → improved |
Epidemiology
Candida spp. are normal commensals of the gastrointestinal tract,53,54 whereas Aspergillus spp. and Pneumocystis spp. are ubiquitous in nature55–58 and are the cause of fungal infections worldwide. Cryptococcus spp. and Scedosporium spp. are endemic mycoses that also have worldwide distribution. Cryptococcus spp. have been isolated from pigeon droppings,59 while Scedosporium spp. have been found in tidal flats, swamps, ponds, manure, and soil.60,61 Aspergillus spp. and Cryptococcus spp. can also be found as a component of human colonic mycobiota.62
Zygomycetes can be divided into two orders, Mucorales and Entomophthorales. Mucorales are endemic fungi found worldwide in organic substrates, including bread, fruits, vegetable matter, soil, compost, and animal excreta.63 Histoplasma spp., Entomophthorales, Paracoccidioides spp., and Penicillium spp. are endemic mycoses that have been isolated from soil in a number of regions of the world.63–71 Histoplasma spp. are found in soil enriched with bat, chicken, and blackbird droppings.64,65 Entomophthorales can be divided into Conidiobolus spp. and Basidiobolus spp. and are found in the soil of some tropical regions, especially Africa, South America, Central America, and Asia.63 Paracoccidioides spp. are limited to soil in Central and South American countries between 23° north (southern Mexico) and 34.5° north (Argentina and Uruguay). These areas have unique ecologic features, being tropical and subtropical forests with mild temperatures and high humidity.66,67 Penicillium spp. are also isolated from soil in specific areas including Southeast Asia, southern China (Guangxi), Hong Kong, and India.68–71 The epidemiologic data is summarized in Table 5.
Table 5.
Fungi | Epidemiology |
---|---|
Aspergillus spp.,55,56
Candida spp.,53,54
Cryptococcus spp.,59
Histoplasma spp.,64,65 Mucorales,63 Pneumocystis spp.,57,58 Scedosporium spp.60,61 |
Worldwide |
Entomophthorales63 | Tropical areas in Africa, South America, Central America, and Asia |
Paracoccidioides spp.66,67 | South and Central American countries, particularly in Brazil, Colombia, Venezuela, and Argentina |
Penicillium spp.68–71 | Southeast Asia, southern China (Guangxi), Hong Kong, and India |
Prevalence of colonic involvement
The degree of colonic involvement of fungal infections varies according to fungal type, as detailed in Table 6. Paracoccidioidomycosis and histoplasmosis are the most common colonic infections caused by fungi, with a prevalence of 29%72 and 28%,20 respectively. In contrast, penicilliosis, zygomycosis, pneumocystosis, and scedosporiosis rarely infiltrate the colon, with penicilliosis and zygomycosis occurring in 1.9%68 and 0.85% of colonic infections,25 respectively. Both pneumocystosis and scedosporiosis are known only from one case report.51,52 Excluding oropharyngeal candidiasis, the colon is the third most common gastrointestinal organ to be involved in candidiasis following the esophagus and stomach. The colon is involved in 20% of gastrointestinal candidiasis.73 Colonic cryptococcosis is the most common gastrointestinal manifestation of disseminated or pulmonary cryptococcosis, with a prevalence of about 17%.32
Table 6.
Fungal infections | Prevalence of colonic involvement | Comments |
---|---|---|
Paracoccidioidomycosis72 | 29% | Prevalence ascertained by autopsy series |
Histoplasmosis20 | 28% | |
Candidiasis73 | 20% of gastrointestinal candidiasis (excluding oropharyngeal candidiasis) | Prevalence ascertained by autopsy series Only seven symptomatic cases |
Cryptococcosis32 | 17% of disseminated or pulmonary cryptococcosis | |
Aspergillosis74 | 9.2% | |
Penicilliosis68 | 1.9% | Only four cases |
Zygomycosis25 | 0.85% | |
Pneumocystosis51 | No data | Only one case |
Scedosporiosis52 | No data | Only one case |
Risk factors
Colonic cryptococcosis and zygomycosis often occur in immunocompromised hosts, occurring in 77%26–35 and 67%22 of infections respectively, while colonic candidiasis,13 penicilliosis,36–38 and aspergillosis9,39–44 exclusively occur in immunocompromised hosts. Risk factors for these infections are malignancy, taking immunosuppressive agents, chemotherapy, neutropenia, AIDS, renal failure, splenectomy, Job’s syndrome, cirrhosis, malnutrition, and diabetes mellitus; however, most colonic penicilliosis patients usually have AIDS.37,38 There have also been case reports of colonic pneumocystosis and scedosporiosis in immunocompromised patients with AIDS and post-liver transplantation, respectively.51,52 In colonic paracoccidioidomycosis and histoplasmosis, there are no necessary risk factors present.20,21,45–50 As shown in Table 7, males predominate in nearly all fungal infections, except for colonic candidiasis, aspergillosis, and paracoccidioidomycosis. The higher frequency of fungal infections in men may be attributed to their more intense exposure to the endemic fungi habitats through work.67 There is no sex preference in colonic candidiasis, since Candida spp. are normal commensals of the human gut.13,53,54 Aspergillus spp. are ubiquitous, thus sex is also not a risk factor for infection.9,39–44,55,56 Although Paracoccidioidomycosis usually occur in men,67 females predominate are found in colonic paracoccidioidomycosis.45–50 The author suggests that it may be caused by reporting bias.
Table 7.
Fungal infections | Immunocompetent | Immunocompromised | Risk factors | Male | Comments |
---|---|---|---|---|---|
Paracoccidioidomycosis45–50 | 100% | 0% | – | 29% | |
Histoplasmosis20,21 | 81% | 19% | Malignancy, immunosuppressive drugs, AIDS, Job’s syndrome, DM, splenectomy | 76%–86.5% | |
Candidiasis13 | 0% | 100% | Malignancy, immunosuppressive agents, neutropenia, AIDS, ESRD | 43% | |
Cryptococcosis26–35 | 23% | 77% | AIDS, immunosuppressive agents, hematologic malignancy, splenectomy, Job’s syndrome, cirrhosis | 64% | |
Aspergillosis9,39–44 | 0% | 100% | Malignancy, chemotherapy, neutropenia, Immunosuppressive agents, DM, burn | 33% | |
Penicilliosis36–38 | 0% | 100% | AIDS (75%), immunosuppressive agents | 100% | |
Zygomycosis22,24 | 33% | 67% | Immunosuppressive agents, malnutrition, renal failure, DM, hematologic malignancy | 65% | |
Pneumocystosis51 | 0% | 100% | AIDS | 100% | Only one case |
Scedosporiosis52 | 0% | 100% | Post-liver transplantation, immunosuppressive agents | 100% | Only one case |
Abbreviations: AIDS, acquired immunodeficiency syndrome; DM, diabetes mellitus; ESRD, end-stage renal disease.
Immunity and colonic infection caused by fungi
Host immune response to fungi may play an important role in the pathogenesis of colonic infection caused by fungi, especially organisms that are part of the microbiota.75,76 Normally, innate immune cells have membrane-bound and soluble receptors to eliminate fungi. Membrane-bound receptors such as lectin, a toll-like scavenger, and complement receptors can detect fungi or fungal products and then activate phagocytosis and respiratory burst. Transcription factors which can induce proinflammatory cytokines and chemokines are also activated by membrane-bound receptors. Soluble receptors can further activate complements and opsonize fungi to complement receptors. Finally, T helper (Th) 1 and 17 are triggered and produce other cytokines including interleukin (IL)-17A, IL-17F, and IL-22 for adaptive immunity. Both innate and adaptive immune systems defend the host against fungi.76
There is some evidence that impaired immunity can increase colonic infection. IL-22, which is produced by innate cells and regulated by IL-23, has been demonstrated to activate inflammatory cells and thus control initial fungal growth.75 Defective IL-23 and IL-22 pathways increase the fungal burden in the gastrointestinal tract; nevertheless, Th1 cells prevent dissemination of fungi. Th17 cells play a major role in adaptive immune responses, though their impairment results in decreased resistance to late fungal infection. IL-17 receptor A deficiency reduces Th1 activation, thus decreasing fungal resistance.75 Therefore, immunosuppressive status is one of the major predisposing factors for colonic infection caused by fungi.
Clinical manifestations
Colonic infections caused by fungi have varied clinical manifestations, as detailed in Table 8. Excluding zygomycosis and aspergillosis, more than one-half of patients with colonic fungal infections have disseminated disease. Abdominal pain is the most common presentation in colonic zygomycosis and aspergillosis.9,22,24,39–44 Deep tissue involvement and angioinvasion, which are common pathological findings in both aspergillosis and zygomycosis, may explain these manifestations.22,25,74 Diarrhea is a symptom that is often found in paracoccidioidomycosis and candidiasis.13,45–50 Cases of colonic histoplasmosis and penicilliosis include diarrhea and abdominal pain as predominant symptoms.20,21,36–38 Perirectal abscess is a specific feature that is only found in colonic cryptococcosis.28,29 Fever is a usual finding in fungal infection of the colon, especially in cases of colonic penicilliosis patients, all of whom experience fever.36–38 For example, a case of colonic pneumocystosis presented with fever and diarrhea,51 while one with colonic scedosporiosis presented with diarrhea and abdominal pain.52
Table 8.
Fungal infections | Dissemination | Diarrhea | Abdominal pain | LGIB | Rectal abscess | Fever | Comments |
---|---|---|---|---|---|---|---|
Paracoccidioidomycosis45–50 | 50% | 75% | 38% | – | – | 50% | Asymptomatic in 12.5% |
Histoplasmosis20,21 | 83% | 83% | 67% | 32% | – | 77% | – |
Candidiasis13 | 71% | 57% | 29% | 29% | – | 71% | – |
Cryptococcosis26–35 | 71% (all patients immunocompromised) | 20% | 30% | 40% | 20% | 30% | Asymptomatic in 20% |
Aspergillosis9,39–44 | 33% | 22% | 56% | 33% | – | 67% | – |
Penicilliosis36–38 | 50% | 75% | 75% | 25% | – | 100% | – |
Zygomycosis22,24 | 38% | 18% | 64% | 18% | – | 55% | – |
Pneumocystosis51 | 100% | 100% | – | – | – | 100% | Only one case |
Scedosporiosis52 | 100% | 100% | 100% | – | – | – | Only one case |
Pathological findings and distribution
Colonic ulcer is the most common pathological finding in patients with fungal infection of the colon, as shown in Table 9. All cases of colonic aspergillosis, and penicilliosis have ulcers.36–38,74 Ulcer is also usually found in colonic histoplasmosis, paracoccidioidomycosis, and candidiasis.21,45–50,73 Colonic scedosporiosis, likewise, presents with ulcer.52 On the contrary, colonic cryptococcosis presents with a mass or polyp as the most common pathologic finding, while colonic cryptococcosis may also present with atypical pathologic findings, including rectal abscess or stricture.26–35 Another colonic infection that can present with a mass or polyp is histoplasmosis.21 In one case of colonic pneumocystosis, the patient presented with bowel edema.51
Table 9.
Fungal infections | Ulcer | Inflamed mucosa/erosion | Pseudomembrane | Mass/polyp | Rectal abscess | Stricture | Comment |
---|---|---|---|---|---|---|---|
Paracoccidioidomycosis45–50 | 63% | – | – | 25% | – | 13% | |
Histoplasmosis21 | 79% | 14% | – | 7% | – | – | |
Candidiasis73 | 64% | 14% | 23% | – | – | – | From autopsy series |
Cryptococcosis26–35 | 11% | 11% | – | 44% | 22% | 11% | |
Aspergillosis74 | 100% (with necrosis 55.6%) | – | – | – | – | – | From autopsy series |
Penicilliosis36–38 | 100% | – | – | – | – | – | |
Zygomycosis22,25 | – | – | – | – | – | – | Ulcer, necrosis, mass occured, but numbers of patients not specified |
Pneumocystosis51 | – | 100% | – | – | – | – | Only one case |
Scedosporiosis52 | 100% | – | – | – | – | – | Only one case |
Distributions of colonic infection caused by fungi differ according to fungus type, as shown in Table 10. Colonic histoplasmosis, zygomycosis, and penicilliosis tend to occur in the right side of the colon.20,23,36–38 The rectal area tends to be involved in cases of histoplasmosis, candidiasis, and zygomycosis.13,20,23 Colonic cryptococcosis is the only fungus that involves the perirectal area.28,29 Diffuse involvement of the colon is commonly found in colonic paracoccidioidomycosis.45–50 Cases of both colonic pneumocystosis and scedosporiosis also presented with diffuse lesions.51,52
Table 10.
Fungal infections | Cecum or ascending colon or appendix | Transverse colon | Descending or sigmoid colon | Rectum | Perirectum | Whole colon | Comments |
---|---|---|---|---|---|---|---|
Paracoccidioidomycosis45–50 | 13% | 25% | 13% | – | – | 50% | |
Histoplasmosis20 | 66% | – | 8% | 26% | – | – | |
Candidiasis13 | 20% | – | 40% | 20% | – | 20% | |
Cryptococcosis27–30,32–35 | 30% | 10% | 40% | – | 20% | – | |
Aspergillosis9,39–44 | 33% | 22% | 22% | – | – | 22% | |
Penicilliosis36–38 | 50% | 25% | 25% | – | – | – | |
Zygomycosis23 | 50% | – | 18% | 7% | – | 25% | |
Pneumocystosis51 | – | – | – | – | – | 100% | Only one case |
Scedosporiosis52 | – | – | – | – | – | 100% | Only one case |
Treatment response
Amphotericin B is the most commonly used drug to treat nearly all colonic fungal infections except candidiasis and pneumocystosis. Colonic candidiasis responds to fluconazole or caspofungin and has the best prognosis if antifungal therapy is initiated with 100% compliance.13 Good response was also achieved in colonic pneumocystosis and scedosporiosis.51,52 A case of colonic pneumocystosis was treated with intravenous pentamidine due to sulfamethoxazole–trimethoprim allergy.51 Combined antifungal therapy and surgery have been used to treat gastrointestinal zygomycosis and aspergillosis due to angioinvasion and infarction. Nevertheless, prognosis is still poor in these cases, with 50% mortality.25,39,41,43,44 The choices of antibiotic and treatment response of fungal infections are summarized in Table 11.
Table 11.
Fungal infections | Treatment | Treatment response | Comments |
---|---|---|---|
Paracoccidioidomycosis45,47–50 | Co-trimoxazole, sulfadiazine, amphotericin B, or itraconazole | 71% | |
Histoplasmosis21 | Amphotericin B | 77% | |
Candidiasis13 | Fluconazole or caspofungin | 100% | |
Cryptococcosis27–35 | Amphotericin B + flucytosine ± surgery | 67% | Response to treatment in immunocompetent patients was 100% |
Aspergillosis39,41,43,44 | Amphotericin B or caspofungin ± surgery | 50% | |
Penicilliosis36–38 | Amphotericin B | 75% | |
Zygomycosis25 | Amphotericin B + surgery | 50% | Combined surgery improved treatment response |
Pneumocystosis51 | Pentamidine | 100% | Only one case |
Scedosporiosis52 | Amphotericin B | 100% | Only one case |
Conclusion
This is the first study to intensively review the literature on fungal infections of the colon. The entire content is summarized in Table 12. It provides basic information on causes, manifestations, and management and can be easily applied in clinical practice. Physicians should be aware of this fungal entity when patients have colonic symptoms, especially in immunocompromised cases. Although many fungal infections have been reported to cause colonic disease, including aspergillosis, candidiasis, cryptococcosis, histoplasmosis, paracoccidioidomycosis, penicilliosis, pneumocystosis, scedosporiosis, and zygomycosis, knowing the differences in epidemiology, risk factors, clinical manifestations, and pathological findings will help physicians to better diagnosis and manage these infections. Appropriate treatment with antifungal therapy definitely improves outcomes; nevertheless, zygomycosis and aspergillosis cases still have high mortality rates.
Table 12.
Fungal infections | Prevalence of colonic involvement | Risk factors | Clinical manifestations | Dissemination | Lesions | Distribution | Initial treatment | Response |
---|---|---|---|---|---|---|---|---|
Paracoccidioidomycosis45–50,72 | 29% | • Endemic area (South America) • Any host |
Diarrhea, abdominal pain, fever | 50% | Ulcer, mass, polyp, stricture | Whole colon | Co-trimoxazole, sulfadiazine, amphotericin B, or itraconazole | 71% |
Histoplasmosis20,21 | 28% | • Any host | Diarrhea, abdominal pain, LGIB, fever, weight loss | 83% | Ulcer, edema mucosa mass | Whole colon but predominantly right side of colon and rectum | Amphotericin B | 77% |
Candidiasis13,73 | 20% of intestinal candidiasis in autopsy | • Malignancy, immunosuppressive agents, neutropenia, AIDS, ESRD • No immunocompetent patients |
Diarrhea, abdominal pain, fever | 71% | Ulcer, plaque, erosion | Whole colon | Fluconazole or caspofungin | 100% |
Cryptococcosis26–35 | 17% of disseminated or pulmonary cryptococcosis | • AIDS, immunosuppressive agents, hematologic malignancy, splenectomy, Job’s syndrome, cirrhosis • Immunocompetent patients (23%) |
• Symptoms: LGIB, fever, abdominal pain, diarrhea, rectal abscess • 20% asymptomatic |
71% (all patients immunocompromised) | Mass, perirectal abscess, colonic ulcer, patchy lesions, stricture, polyp | Whole colon | Amphotericin B + flucytosine ± surgery | 60% |
Aspergillosis9,39–44,74 | 9.2% | • Malignancy, chemotherapy, neutropenia, immunosuppressive agents, DM, burn • No immunocompetent patients |
Fever, abdominal pain, LGIB, diarrhea | 86% | Ulcer, necrosis | Whole colon | Amphotericin B or caspofungin ± surgery | 50% |
Penicilliosis36–38,68 | 1.9% | • Endemic area (Southeast Asia, southern China, Hong Kong, and India) • Mostly AIDS (75%) • No immunocompetent patients |
Fever, diarrhea, abdominal pain, LGIB | 50% | Ulcer | Predominantly in right side of colon and spare rectum | Amphotericin B | 75% |
Zygomycosis22–25 | 0.85% | • Immunosuppressive agent, malnutrition, renal failure, DM, hematologic malignancy • I mmunocompetent patients (33.3%) |
Abdominal pain, abdominal distension, fever, LGIB, diarrhea | 38% | Ulcer, necrosis, mass | Whole colon but predominantly in the right side of the colon | Amphotericin B + surgery | 50% |
Pneumocystosis51 | Only one case | • AIDS | Fever, diarrhea | 100% | Edema mucosa | Whole colon | Pentamidine | 100% |
Scedosporiosis52 | Only one case | • Post-liver transplantation, immunosuppressive agents | Diarrhea, abdominal pain | 100% | Ulcer | Whole colon | Amphotericin B | 100% |
Abbreviations: AIDS, acquired immunodeficiency syndrome; DM, diabetes mellitus; ESRD, end-stage renal disease; LGIB, lower gastrointestinal bleeding.
Table 2.
Source, year | Age (years)/sex | Origin of report | Underlying disease/medication | Clinical presentations | Duration of onset | Dissemination | Colonic distribution | Endoscopic finding | Treatment and outcome |
---|---|---|---|---|---|---|---|---|---|
Tsang et al,36 1988 | 58/male | Hong Kong | Corticosteroids | Fever, anemia, hepatosplenomegaly | Acute | Yes | Descending colon | Ulcer | Amphotericin B → died |
Leung et al,37 1996 | 32/male | Hong Kong | AIDS | Fever, diarrhea, night sweats, dry cough | Acute | No | Cecum, transverse and descending colons | Ulcer | Amphotericin B and itraconazole → improved |
Ko et al,38 1999 | 52/male | Taiwan | AIDS | Fever, diarrhea, anemia, abdominal pain | 3 weeks | Yes | Cecum | Ulcer | Amphotericin B and itraconazole → improved |
Ko et al,38 1999 | 30/male | Taiwan | AIDS | Dyspepsia, diarrhea, fever, abdominal pain, LGIB, weight loss | 2 months | No | Cecum, ascending and transverse colons | Ulcer | Amphotericin B and itraconazole → improved |
Abbreviations: AIDS, acquired immunodeficiency syndrome; LGIB, lower gastrointestinal bleeding.
Table 3.
Source, year | Age (years)/sex | Origin of report | Underlying disease/medication | Clinical presentations | Duration of onset | Dissemination | Colonic distribution | Endoscopic finding | Treatment and outcome | Diagnosed from |
---|---|---|---|---|---|---|---|---|---|---|
Kinder and Jourdan,39 1985 | 37/female | UK | Post-renal transplant, immunosuppressive agents | LGIB | Acute | Yes | Cecum and sigmoid colon | Ulcer | Amphotericin B and surgery → died | Deep tissue involvement in surgical specimen |
Prescott et al,9 1992 | 62/female | UK | AML, chemotherapy, neutropenia | Fever, abdominal pain, diarrhea, and vomiting | Acute | No | Not mentioned | Ulcer | Not mentioned → died | Deep tissue involvement in autopsy |
Prescott et al,9 1992 | 43/male | UK | CML, chemotherapy, neutropenia | Fever | Acute | Yes | Transverse colon | Pseudomembrane | Not mentioned → died | No deep tissue involvement in colon but definite other organ involvement |
Prescott et al,9 1992 | 66/female | UK | CA stomach, chemotherapy, neutropenia | Fever | Acute | Yes | Transverse colon | Necrosis | Not mentioned → died | Deep tissue involvement in autopsy |
Sousa et al,40 2002 | 21/female | Portugal | Aplastic anemia | Fever, abdominal pain | Subacute | No | Cecum | Mass | Surgery → died | Deep tissue involvement in surgical specimen |
Finn et al,41 2006 | 75/female | Ireland | Aplastic anemia, immunosuppressive agents | Fever, abdominal pain | Acute | No | Cecum | Ulcer with necrosis | Amphotericin B and surgery → died | Deep tissue involvement in surgical specimen |
Andres et al,42 2007 | 42/female | USA | Burn | Abdominal pain, distension, LGIB | Acute | No | Whole colon | Necrosis | None | Deep tissue involvement in surgical specimen |
Mohite et al,43 2007 | 42/male | UK | AML, chemotherapy, neutropenia | Fever, diarrhea, abdominal pain, Abdominal distension | Acute | No | Whole colon | Ulcer with necrosis | Caspofungin and surgery → improved | Deep tissue involvement in surgical Specimen and responded to treatment |
Choi et al,44 2010 | 72/male | Korea | DM, steroid, CA colon | LGIB | Acute | No | Sigmoid colon and descending colon | Ulcer | Amphotericin B → improved | Responded to treatment |
Abbreviations: AML, acute myeloid leukemia; CA, cancer; CML, chronic myeloid leukemia; DM, diabetes mellitus; LGIB, lower gastrointestinal bleeding.
Footnotes
Disclosure
The author reports no conflicts of interest in this work.
References
- 1.Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical Mycology. New York, NY: Churchill Livingstone; 2003. [Google Scholar]
- 2.Dismukes WE, Pappas PG, Sobel JD, editors. Clinical Mycology. New York, NY: Oxford University Press; 2003. [Google Scholar]
- 3.Hospenthal DR, Rinaldi MG, editors. Diagnosis and Treatment of Human Mycoses. Totowa, NJ: Humana Press; 2008. [Google Scholar]
- 4.Smith JM. Mycoses of the alimentary tract. Gut. 1969;10:1035–1040. [PMC free article] [PubMed] [Google Scholar]
- 5.Schmitt SL, Wexner SD. Bacterial, fungal, parasitic, and viral colitis. Surg Clin North Am. 1993;73(5):1055–1062. doi: 10.1016/s0039-6109(16)46140-2. [DOI] [PubMed] [Google Scholar]
- 6.Lima AAM, Guerrant RL. Inflammatory enteritides. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2009. pp. 1389–1398. [Google Scholar]
- 7.Wilcox CM. Gastrointestinal consequences of infection with human immunodeficiency virus. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. 9th ed. Philadelphia, PA: Saunders Elsevier; 2010. pp. 523–535. [Google Scholar]
- 8.Stylianos S, Forde KA, Benvenisty Al, Hardy MA. Lower gastrointestinal hemorrhage in renal transplant recipients. Arch Surg. 1988;123:739–744. doi: 10.1001/archsurg.1988.01400300085015. [DOI] [PubMed] [Google Scholar]
- 9.Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol. 1992;45:806–811. doi: 10.1136/jcp.45.9.806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jayagopal S, Cervia JS. Colitis due to Candida albicans in a patient with AIDS. Clin Infect Dis. 1992;15:555. doi: 10.1093/clind/15.3.555. [DOI] [PubMed] [Google Scholar]
- 11.Kouklakis G, Dokas S, Molyvas E, Vakianis P, Efthymiou A. Candida colitis in a middle-aged male receiving permanent haemodialysis. Eur J Gastroenterol Hepatol. 2001;13:735–736. doi: 10.1097/00042737-200106000-00021. [DOI] [PubMed] [Google Scholar]
- 12.Kitagawa KH, Kalb RE. Efalizumab treatment associated with Candida colitis. J Am Acad Dermatol. 2008;59(suppl 5):S120–S121. doi: 10.1016/j.jaad.2008.06.035. [DOI] [PubMed] [Google Scholar]
- 13.Praneenararat S. The first reported case of colonic infection caused by Candida tropicalis and a review of the literature. Case Rep Gastroenterol. 2014;8:199–205. doi: 10.1159/000363566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–1821. doi: 10.1086/588660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ascioglu S, Rex JH, de Pauw B, et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer. Mycoses Study Group of the National Institute of Allergy and Infectious Diseases Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14. doi: 10.1086/323335. [DOI] [PubMed] [Google Scholar]
- 16.Safdar A, Singhal S, Mehta J. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993–2001) Cancer. 2004;100:2456–2461. doi: 10.1002/cncr.20262. [DOI] [PubMed] [Google Scholar]
- 17.Kontoyiannis DP, Bodey GP, Hanna H, et al. Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recovery. Leuk Lymphoma. 2004;45:139–141. doi: 10.1080/1042819031000149386. [DOI] [PubMed] [Google Scholar]
- 18.Lionakis MS, Bodey GP, Tarrand JJ, Raad II, Kontoyiannis DP. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect. 2004;10:922–925. doi: 10.1111/j.1469-0691.2004.00933.x. [DOI] [PubMed] [Google Scholar]
- 19.Safdar A, Rodriguez G, Rolston KV, et al. High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39(3):157–164. doi: 10.1038/sj.bmt.1705559. [DOI] [PubMed] [Google Scholar]
- 20.Cappell MS, Mandell W, Grimes MM, Neu HC. Gastrointestinal histoplasmosis. Dig Dis Sci. 1988;33:353–360. doi: 10.1007/BF01535762. [DOI] [PubMed] [Google Scholar]
- 21.Assi M, McKinsey DS, Driks MR, et al. Gastrointestinal histoplasmosis in the acquired immunodeficiency syndrome: report of 18 cases and literature review. Diagn Microbiol Infect Dis. 2006;55:195–201. doi: 10.1016/j.diagmicrobio.2006.01.015. [DOI] [PubMed] [Google Scholar]
- 22.Lyon DT, Schubert TT, Mantia AG, Kaplan MH. Phycomycosis of the gastrointestinal tract. Am J Gastroenterol. 1979;72(4):379–394. [PubMed] [Google Scholar]
- 23.Agha FP, Lee HH, Boland CR, Bradley SF. Mucormycoma of the colon: early diagnosis and successful management. AJR Am J Roentgenol. 1985;145:739–741. doi: 10.2214/ajr.145.4.739. [DOI] [PubMed] [Google Scholar]
- 24.Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–653. doi: 10.1086/432579. [DOI] [PubMed] [Google Scholar]
- 25.Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6:2365–2374. doi: 10.1111/j.1600-6143.2006.01496.x. [DOI] [PubMed] [Google Scholar]
- 26.Zelman S, O’Neil RH, Plaut A. Disseminated visceral torulosis without nervous system involvement with clinical appearance of granulocytic leukemia. Am J Med. 1951;11:658–664. doi: 10.1016/0002-9343(51)90098-8. [DOI] [PubMed] [Google Scholar]
- 27.Unat EK, Pars B, Kosyak JP. A case of cryptococcosis of the colon. Br Med J. 1960;2:1501–1502. doi: 10.1136/bmj.2.5211.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI. Cryptococcosis of the colon resembling Crohn’s disease in a patient with the hyperimmunoglobulinemia E recurrent infection (Job’s) syndrome. Gastroenterology. 1988;94:808–812. doi: 10.1016/0016-5085(88)90257-0. [DOI] [PubMed] [Google Scholar]
- 29.Van Calck M, Motte S, Rickaert F, Serruys E, Adler M, Wybran J. Cryptococcal anal ulceration in a patient with AIDS. Am J Gastroenterol. 1988;83:1306–1308. [PubMed] [Google Scholar]
- 30.Daly JS, Porter KA, Chong FK, Robillard RJ. Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient. Am J Gastroenterol. 1990;85:1421–1424. [PubMed] [Google Scholar]
- 31.Bonacini M, Nussbaum J, Ahluwalia C. Gastrointestinal, hepatic, and pancreatic involvement with Cryptococcus neoformans in AIDS. J Clin Gastroenterol. 1990;12:295–297. doi: 10.1097/00004836-199006000-00012. [DOI] [PubMed] [Google Scholar]
- 32.Washington K, Gottfried MR, Wilson ML. Gastrointestinal cryptococcosis. Mod Pathol. 1991;4:707–711. [PubMed] [Google Scholar]
- 33.Melato M, Gorji N. Primary intestinal cryptococcosis mimicking adenomatous polyp in an HIV-negative patient. Am J Gastroenterol. 1998;93:1592–1593. doi: 10.1111/j.1572-0241.1998.00492.x. [DOI] [PubMed] [Google Scholar]
- 34.Law JK, Amar JN, Kirby SD, Zetler PJ, Enns RA. Colonic cryptococcus infection. Gastrointest Endosc. 2007;65:525–526. doi: 10.1016/j.gie.2006.08.043. [DOI] [PubMed] [Google Scholar]
- 35.Song JC, Kim SK, Kim ES, et al. A case of colonic cryptococcosis. Korean J Gastroenterol. 2008;52:255–260. Korean. [PubMed] [Google Scholar]
- 36.Tsang DN, Chan JK, Lau YT, Lim W, Tse CH, Chan NK. Penicillium marneffei infection: an underdiagnosed disease? Histopathology. 1988;13:311–318. doi: 10.1111/j.1365-2559.1988.tb02041.x. [DOI] [PubMed] [Google Scholar]
- 37.Leung R, Sung JY, Chow J, Lai CK. Unusual cause of fever and diarrhea in a patient with AIDS. Penicillium marneffei infection. Dig Dis Sci. 1996;41:1212–1215. doi: 10.1007/BF02088239. [DOI] [PubMed] [Google Scholar]
- 38.Ko CI, Hung CC, Chen MY, Hsueh PR, Hsiao CH, Wong JM. Endoscopic diagnosis of intestinal penicilliosis marneffei: report of three cases and review of the literature. Gastrointest Endosc. 1999;50(1):111–114. doi: 10.1016/s0016-5107(99)70359-7. [DOI] [PubMed] [Google Scholar]
- 39.Kinder RB, Jourdan MH. Disseminated aspergillosis and bleeding colonic ulcers in renal transplant patient. J R Soc Med. 1985;78(4):338–339. doi: 10.1177/014107688507800414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sousa AB, Ferreira G, Veiga J, Carvalho A. Clinical picture: bowel infarction due to aspergillosis. Lancet. 2002;359(9302):210. doi: 10.1016/s0140-6736(02)07446-9. [DOI] [PubMed] [Google Scholar]
- 41.Finn S, Bond J, McCarthy D, Sheahan K, Quinn C. Angioinvasive aspergillosis presenting as neutropenic colitis. Histopathology. 2006;49(4):440–441. doi: 10.1111/j.1365-2559.2006.02488.x. [DOI] [PubMed] [Google Scholar]
- 42.Andres LA, Ford RD, Wilcox RM. Necrotizing colitis caused by systemic aspergillosis in a burn patient. J Burn Care Res. 2007;28(6):918–921. doi: 10.1097/BCR.0b013e318159a3d8. [DOI] [PubMed] [Google Scholar]
- 43.Mohite U, Kell J, Haj MA, et al. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol. 2007;78:270–273. doi: 10.1111/j.1600-0609.2006.00812.x. [DOI] [PubMed] [Google Scholar]
- 44.Choi SH, Chung JW, Cho SY, Kim BJ, Kwon GY. A case of isolated invasive Aspergillus colitis presenting with hematochezia in a nonneutropenic patient with colon cancer. Gut Liver. 2010;4(2):274–277. doi: 10.5009/gnl.2010.4.2.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Penna FJ. Blastomycosis of the colon resembling ulcerative colitis. Gut. 1979;20:896–899. doi: 10.1136/gut.20.10.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Chojniak R, Costa Vieira RA, Lopes A, et al. Intestinal paracoccidioidomycosis simulating colon cancer. Rev Soc Bras Med Trop. 2000;33:309–312. doi: 10.1590/s0037-86822000000300010. [DOI] [PubMed] [Google Scholar]
- 47.Costa Vieira RA, Lopes A, Oliveira HV, et al. Anal paracoccidioidomycosis: an unusual presentation of disseminated disease. Rev Soc Med Trop. 2001;34:583–586. doi: 10.1590/s0037-86822001000600014. [DOI] [PubMed] [Google Scholar]
- 48.Bravo EA, Zegarra AJ, Piscoya A, et al. Chronic diarrhea and pancolitis caused by paracoccidioidomycosis: case report. Case Report Med. 2010;2010:140505. doi: 10.1155/2010/140505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.León M, Alave J, Bustamante B, Cok J, Gotuzzo E, Seas C. Human T lymphotropic virus 1 and paracoccidioidomycosis: a probable association in Latin America. Clin Infect Dis. 2010;51(2):250–251. doi: 10.1086/653679. [DOI] [PubMed] [Google Scholar]
- 50.Benard G, Costa AN, Leopércio AP, Vicentini AP, Kono A, Shikanai-Yasuda MA. Chronic paracoccidioidomycosis of the intestine as single organ involvement points to an alternative pathogenesis of the mycosis. Mycopathologia. 2013;176(5–6):353–357. doi: 10.1007/s11046-013-9699-z. [DOI] [PubMed] [Google Scholar]
- 51.Bellomo AR, Perlman DC, Kaminsky DL, Brettholz EM, Sarlin JG. Pneumocystis colitis in a patient with the acquired immunodeficiency syndrome. Am J Gastroenterol. 1992;87(6):759–761. [PubMed] [Google Scholar]
- 52.Lin D, Kamili Q, Lai S, Musher DM, Hamill R. Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations. Infection. 2013;41(3):723–726. doi: 10.1007/s15010-013-0429-8. [DOI] [PubMed] [Google Scholar]
- 53.Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology. 1967;53:845–855. [PubMed] [Google Scholar]
- 54.Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Engl J Med. 1969;280:638–641. doi: 10.1056/NEJM196903202801204. [DOI] [PubMed] [Google Scholar]
- 55.Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781–803. doi: 10.1086/513943. [DOI] [PubMed] [Google Scholar]
- 56.Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am. 2002;16:875–894. doi: 10.1016/s0891-5520(02)00035-1. vi. [DOI] [PubMed] [Google Scholar]
- 57.Smulian AG, Keely SP, Sunkin SM, Stringer JR. Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J Lab Clin Med. 1997;130(5):461–468. doi: 10.1016/s0022-2143(97)90122-0. [DOI] [PubMed] [Google Scholar]
- 58.Daly KR, Koch J, Levin L, Walzer PD. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis. 2004;10(5):848–854. doi: 10.3201/eid1005.030497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20:507–544. doi: 10.1016/j.idc.2006.07.001. [DOI] [PubMed] [Google Scholar]
- 60.Salkin IF, McGinnis MR, Dykstra MJ, Rinaldi MG. Scedosporium inflatum, an emerging pathogen. J Clin Microbiol. 1988;26:498–503. doi: 10.1128/jcm.26.3.498-503.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Summerbell RC, Krajden S, Kane J. Potted plants in hospitals as reservoirs of pathogenic fungi. Mycopathologia. 1989;106:13–22. doi: 10.1007/BF00436921. [DOI] [PubMed] [Google Scholar]
- 62.Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One. 2013;8(6):e66019. doi: 10.1371/journal.pone.0066019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am. 2006;20:581–607. doi: 10.1016/j.idc.2006.06.003. [DOI] [PubMed] [Google Scholar]
- 64.Goodwin RA, Jr, Shapiro JL, Thurman GH, Thurman SS, Des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 1980;59:1–33. [PubMed] [Google Scholar]
- 65.Wheat LJ, Slama TG, Eitzen HE, Kohler RB, French ML, Biesecker JL. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med. 1981;94:331–337. doi: 10.7326/0003-4819-94-3-331. [DOI] [PubMed] [Google Scholar]
- 66.Negroni R. Paracoccidioidomycosis (South American blastomycosis, Lutz’s mycosis) Int J Dermatol. 1993;32:847–859. doi: 10.1111/j.1365-4362.1993.tb01396.x. [DOI] [PubMed] [Google Scholar]
- 67.Blotta MH, Mamoni RL, Oliveira SJ, et al. Endemic regions of paracoccidioidomycosis in Brazil: a clinical and epidemiologic study of 584 cases in the southeast region. Am J Trop Med Hyg. 1999;61:390–394. doi: 10.4269/ajtmh.1999.61.390. [DOI] [PubMed] [Google Scholar]
- 68.Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet. 1994;344:110–113. doi: 10.1016/s0140-6736(94)91287-4. [DOI] [PubMed] [Google Scholar]
- 69.Wong KH, Lee SS, Lo YC, et al. Profile of opportunistic infections among HIV-1 infected people in Hong Kong. Zhonghua Yi Xue Za Zhi (Taipei) 1995;55:127–136. [PubMed] [Google Scholar]
- 70.Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis. 1996;23:125–130. doi: 10.1093/clinids/23.1.125. [DOI] [PubMed] [Google Scholar]
- 71.Wong KH, Lee SS. Comparing the first and second hundred AIDS cases in Hong Kong. Singapore Med J. 1998;39:236–240. [PubMed] [Google Scholar]
- 72.Peña CE. Deep mycotic infections in Colombia. A clinicopathologic study of 162 cases. Am J Clin Pathol. 1967;47(4):505–520. doi: 10.1093/ajcp/47.4.505. [DOI] [PubMed] [Google Scholar]
- 73.Eras P, Goldstein MJ, Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972;51:367–379. doi: 10.1097/00005792-197209000-00002. [DOI] [PubMed] [Google Scholar]
- 74.Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970;49:147–173. doi: 10.1097/00005792-197003000-00002. [DOI] [PubMed] [Google Scholar]
- 75.De Luca A, Zelante T, D’Angelo C, et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010;3(4):361–373. doi: 10.1038/mi.2010.22. [DOI] [PubMed] [Google Scholar]
- 76.Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014;14(6):405–416. doi: 10.1038/nri3684. [DOI] [PMC free article] [PubMed] [Google Scholar]